Trial NCT02083679

View at ClinicalTrials.gov 
Org. Study IDs: EMR200637-003
Secondary IDs: 2013-003995-11

Last trial update was posted on 2016-10-25

MeSH Interventions

Albumin-Bound Paclitaxel Antibodies, Monoclonal Carboplatin Cisplatin Gemcitabine Paclitaxel Pemetrexed

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions


Stopping Reasons

Sponsor the return rights of the compound to the collaboration partner for further clinical development

Limitations And Caveats

The trial was prematurely discontinued and Expansion Cohort (Part 2) was not conducted as Sponsor decided to prematurely discontinue the development of Sym004. This decision was not related to any safety or efficacy findings regarding Sym004.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID